Noemí Balà Palasí

Noemí Balà Palasí's work experience includes the role of CTO & Founder at Aortyx since October 2018. Prior to this, they served as a Visiting Student at the Massachusetts Institute of Technology from April 2017 to September 2017, where they focused on designing a medical device to treat aortic dissections. Noemí also worked on developing a new graft using a biocompatible material to improve patient outcomes. Earlier in their career, they completed a final degree project at IQAC-CSIC from February 2015 to September 2015, during which they developed an analytical method for monitoring the activity of a specific protein.

Noemí Balà Palasí completed their education in a chronological order as follows:

From 2010 to 2015, they obtained their Bachelor's degree in Chemistry from Universitat de Barcelona.

From 2015 to 2017, they pursued a Master's degree in Pharmaceutical Chemistry at Universitat Ramon Llull.

Finally, from 2018 to 2022, Noemí Balà Palasí completed their Doctorate in Chemical Engineering at Universitat Ramon Llull.